GÜVEN, D. C. Et Al. 2022. The use of fulvestrant before chemotherapy improves survival in hormone-positive breast cancer: a real-life study. TURKISH JOURNAL OF MEDICAL SCIENCES , vol.52, no.5 , 1551-1558.

GÜVEN, D. C., YILDIRIM, H. Ç., ERUL, E., ŞAHİN, T. K., ÇAKIR, İ. Y., AKTEPE, O. H., ... KERTMEN, N.(2022). The use of fulvestrant before chemotherapy improves survival in hormone-positive breast cancer: a real-life study. TURKISH JOURNAL OF MEDICAL SCIENCES , vol.52, no.5, 1551-1558.

GÜVEN, DENİZ Et Al. "The use of fulvestrant before chemotherapy improves survival in hormone-positive breast cancer: a real-life study," TURKISH JOURNAL OF MEDICAL SCIENCES , vol.52, no.5, 1551-1558, 2022

GÜVEN, DENİZ C. Et Al. "The use of fulvestrant before chemotherapy improves survival in hormone-positive breast cancer: a real-life study." TURKISH JOURNAL OF MEDICAL SCIENCES , vol.52, no.5, pp.1551-1558, 2022

GÜVEN, D. C. Et Al. (2022) . "The use of fulvestrant before chemotherapy improves survival in hormone-positive breast cancer: a real-life study." TURKISH JOURNAL OF MEDICAL SCIENCES , vol.52, no.5, pp.1551-1558.

@article{article, author={DENİZ CAN GÜVEN Et Al. }, title={The use of fulvestrant before chemotherapy improves survival in hormone-positive breast cancer: a real-life study}, journal={TURKISH JOURNAL OF MEDICAL SCIENCES}, year=2022, pages={1551-1558} }